3Petrikkos G, Skiada A, Lortholary O, et al. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis,2012,54: 23 -34.
4Ibrahim AS, Spellberg B, Edwards J Jr. Iron acquisition: a novel perspective on mucormycosis pathogenesis and treatment. CmT Opin Infect Dis,2008,21:620-625.
5Agarwal R, Kumar V, Gupta D. Pulmonary mueormycosis : two of a kind. Eur J Intern Med,2006 ,17 :63-65.
6Tedder M, Spratt JA, Anstadt MP, et al. Pulmonary mucormycosis : results of medical and surgical therapy. Ann Thorac Surg, 1994,57 : 1044-1050.
7Ben-Am R, Luna M, Lewis RE, et al. A elinieopathological study of pulmonary mucormycosis in cancer patients: extensiveangioinvasion but limited inflammatory response. J Infect, 2009, 59 : 134-138.
8Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis : the last 30 years. Arch Intern Med, 1999,159 : 1301-1309.
9Karanth M, Taniere P, Barraclough J, et al. A rare presentation of zygomycosis (mucormycosis) andreview of the literature. J Clin Pathol, 2005, 58 : 879-881.
10Shannon VR, Andersson BS, Lei X. Utility of early versus late fiberoptic bronchoscopy in the evaluation of new pulmonary infiltrates following hematopoietic stem cell transplantation. Bone Marrow Transplant, 2010, 45: 647-655.
7Spellberg B, Edwards J, Ibrahim A. Novel Perspectives on mucormycosis: pathophysiology, presentation, and management. Clin Microbiol Rev, 2005, 18: 556-569.
8Ribes JA, Vanover-Sams CL, Baker DJ. Zygomycetes in human disease. Clin Microbiol Rev, 2000, 13: 236-301.
9Petrikkos G, Skiada A, Sambatakou H, et al. Mucormycosis: ten-year experience at a tertiary-care center in Greece. Eur J Clin Microbiol Infect Dis, 2003, 22: 753-756.
10Lee FY, Mossad SB, Adal KA. Pulmonary mucormycosis:the last 30 years. Arch Intern Med, 1999, 159: 1301-1309.
